Cargando…
Arginase and pulmonary diseases
Recent studies have indicated that arginase, which converts l-arginine into l-ornithine and urea, may play an important role in the pathogenesis of various pulmonary disorders. In asthma, chronic obstructive pulmonary disease (COPD) and cystic fibrosis, increased arginase activity in the airways may...
Autores principales: | Maarsingh, Harm, Pera, Tonio, Meurs, Herman |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Springer-Verlag
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2493601/ https://www.ncbi.nlm.nih.gov/pubmed/18437360 http://dx.doi.org/10.1007/s00210-008-0286-7 |
Ejemplares similares
-
Recent Patents in Allergy/Immunology: Use of arginase inhibitors in the treatment of asthma and allergic rhinitis
por: Meurs, Herman, et al.
Publicado: (2019) -
Arginase attenuates inhibitory nonadrenergic noncholinergic nerve-induced nitric oxide generation and airway smooth muscle relaxation
por: Maarsingh, Harm, et al.
Publicado: (2005) -
Arginase strongly impairs neuronal nitric oxide-mediated airway smooth muscle relaxation in allergic asthma
por: Maarsingh, Harm, et al.
Publicado: (2006) -
Anti-Inflammatory Role of the cAMP Effectors Epac and PKA: Implications in Chronic Obstructive Pulmonary Disease
por: Oldenburger, Anouk, et al.
Publicado: (2012) -
Bronchoconstriction Induces TGF-β Release and Airway Remodelling in Guinea Pig Lung Slices
por: Oenema, Tjitske A., et al.
Publicado: (2013)